What, according to you, were the various challenges faced by the companies involved in the disease diagnostics space during the pandemic?
As COVID-19 was a novel virus, detecting, containing, treating and managing the disease proved to be difficult for everyone. Lockdowns across the world to contain the disease posed additional logistical burden. Test, Trace and Treat became the diktat to fight COVID-19 and 'Testing' came under the spotlight.
Initially we faced a challenge in procurement and supply of test kits, reagents and other consumables. This was resolved by working closely with our reliable and sturdy network of suppliers. ICMR quickly validating the newly launched test kits also came in as a huge help.
COVID also forced us to think outside the box- literally, when we set-up a BSL2 level Container Lab in our National Reference Lab in Rohini, Delhi. This helped us processing greater volumes of samples simply by providing a place to unbox and add buffer to the samples before the actual testing started. With this, we were able to insulate our lab premises and staff from threat of COVID.
As everyone was dealing with the unknown, teething troubles with various states in terms of compliance, operations, reporting and pricing were also faced.
Which approaches and techniques are considered suitable (and safe) for diagnosis of infectious diseases today?
Infectious diseases are caused by Bacteria, Viruses, Fungi and Parasites and the clinical symptoms are often a mix complex of fever, cough, cold, diarrhea, rashes, etc. which are generally site specific. The best way to diagnose infectious diseases is to go for site-specific sampling and subject it to PCR (Polymerase Chain Reaction) that detects genetic material from a specific organism. This is the fastest, most sensitive and specific way to detect the causative agent of the infection.
هذه القصة مأخوذة من طبعة December 2022 من Healthcare Radius.
ابدأ النسخة التجريبية المجانية من Magzter GOLD لمدة 7 أيام للوصول إلى آلاف القصص المتميزة المنسقة وأكثر من 9,000 مجلة وصحيفة.
بالفعل مشترك ? تسجيل الدخول
هذه القصة مأخوذة من طبعة December 2022 من Healthcare Radius.
ابدأ النسخة التجريبية المجانية من Magzter GOLD لمدة 7 أيام للوصول إلى آلاف القصص المتميزة المنسقة وأكثر من 9,000 مجلة وصحيفة.
بالفعل مشترك? تسجيل الدخول
Dengue-related searches surge on Justdial
Justdial data reveals significant increase in dengue-related searches and pest control services this monsoon season, amid severe dengue outbreak in India.
Ipca launches NovaLead's Diulcus for diabetic foot ulcer
Ipca Laboratories launches NovaLead's patented drug Diulcus, for the treatment of diabetic foot ulcer in India.
Sahyadri Hospitals unveils advanced radiotherapy treatment
Sahyadri Hospitals launches Asia's first advanced radiotherapy treatment, Radixact X9 system with Vital Hold technology for precise cancer treatment.
Complex liver transplant saves diabetic patient
Wockhardt Hospitals, Mumbai Central and South Asian Liver Institute provide liver transplant services to a Botswanian patient.
Gynecological cancers rise in young Indian women
Experts stress need for awareness, early screening, and advanced treatment options like robotic-assisted surgery for gynecological cancers.
Mahajan Imaging, Siemens unveil AI diagnostic analyzer
Mahajan Imaging and Labs and Siemens Healthineers launch India's first Al-diagnostic analyzer.
Nimotuzumab boosts head and neck cancer survival - Tata Memorial study
A Tata Memorial study finds Nimotuzumab increases 10-year survival rate for head and neck cancer patients.
Kolkata doctor rape and murder: Everything you wanted to know
Protesting doctors demand better workplace safety and stricter policy measures.
AYUSH treatments to be covered under PM-JAY?
Very soon, AYUSH treatments may be covered under AB PM-JAY.
WHAT DOCTORS MUST TELL PATIENTS ABOUT DRY EYE SYNDROME
Dry eye syndrome affects lakhs of people globally, causing discomfort and vision issues. Learn how doctors must guide patients about managing it.